SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-023461
Filing Date
2023-05-22
Accepted
2023-05-22 16:26:28
Documents
67
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q oncr-20230331.htm   iXBRL 10-Q 1962816
2 EX-31.1 oncr-ex31_1.htm EX-31.1 19234
3 EX-31.2 oncr-ex31_2.htm EX-31.2 18586
4 EX-32.1 oncr-ex32_1.htm EX-32.1 11451
5 EX-32.2 oncr-ex32_2.htm EX-32.2 10992
  Complete submission text file 0000950170-23-023461.txt   8140021

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT oncr-20230331_lab.xml EX-101.LAB 386542
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT oncr-20230331_def.xml EX-101.DEF 132873
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT oncr-20230331_pre.xml EX-101.PRE 279361
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT oncr-20230331_cal.xml EX-101.CAL 47074
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT oncr-20230331.xsd EX-101.SCH 45377
61 EXTRACTED XBRL INSTANCE DOCUMENT oncr-20230331_htm.xml XML 1799745
Mailing Address 4 CORPORATE DRIVE ANDOVER MA 01810
Business Address 4 CORPORATE DRIVE ANDOVER MA 01810 857-320-6400
Oncorus, Inc. (Filer) CIK: 0001671818 (see all company filings)

IRS No.: 473779757 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39575 | Film No.: 23944837
SIC: 2834 Pharmaceutical Preparations